BackOsmotica Pharmaceuticals Plc Overview

Osmotica Pharmaceuticals Plc Common Stock

Track Osmotica Pharmaceuticals Plc's common stock ($990K) with charts, peers, and YoY trends.

Get informed when a big investor buys or sells

+ Follow
Common Stock
$994000.00
18.90% YoYΔ $158000.00 vs prior year quarter

Peer average

Loading

Osmotica Pharmaceuticals Plc Common Stock History

Loading

Osmotica Pharmaceuticals Plc vs. peers: Common Stock Comparison

Loading

Osmotica Pharmaceuticals Plc Common Stock Growth (YoY per quarter)

Latest change versus the prior comparable period (same company). Positive growth indicates new issuance/dilution; negative growth indicates reductions/buybacks.

Loading

Osmotica Pharmaceuticals Plc (OSMT) FAQ

As of the most recent data (June 2023), OSMT shows a common stock of $990K. That compares with $840K in the prior-year period — up 18.9% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, OSMT's common stock is now $990K (was $840K) — a 18.9% year-over-year increase. Pairing that YoY change with peer averages gives a clearer picture of whether Osmotica Pharmaceuticals Plc is outperforming or lagging.

Tracking OSMT's common stock over time shows whether Osmotica Pharmaceuticals Plc is scaling, shrinking, or reshaping that part of the business. The current reading is $990K That compares with $840K in the prior-year period — up 18.9% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this common stock page, Stockcircle has Osmotica Pharmaceuticals Plc's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect common stock (currently $990K) with ownership activity and broader fundamentals.

Osmotica Pharmaceuticals Plc's common stock is $990K; compare it with other Healthcare names on the peer chart. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.